Becton Dickinson & Co (BDX)
224.00
-1.45
(-0.64%)
USD |
NYSE |
Nov 22, 16:00
224.04
+0.04
(+0.02%)
Pre-Market: 20:00
Becton Dickinson Cash from Financing (Quarterly): 124.00M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 124.00M |
June 30, 2024 | 1.119B |
March 31, 2024 | 1.705B |
December 31, 2023 | -862.00M |
September 30, 2023 | -998.00M |
June 30, 2023 | -1.794B |
March 31, 2023 | 1.368B |
December 31, 2022 | -533.00M |
September 30, 2022 | -550.00M |
June 30, 2022 | -846.00M |
March 31, 2022 | 1.132B |
December 31, 2021 | -327.00M |
September 30, 2021 | -1.142B |
June 30, 2021 | -1.271B |
March 31, 2021 | -301.00M |
December 31, 2020 | -592.00M |
September 30, 2020 | -1.209B |
June 30, 2020 | 21.00M |
March 31, 2020 | 1.623B |
December 31, 2019 | -413.00M |
September 30, 2019 | -925.00M |
June 30, 2019 | -768.00M |
March 31, 2019 | -797.00M |
December 31, 2018 | -734.00M |
September 30, 2018 | -1.006B |
Date | Value |
---|---|
June 30, 2018 | -616.00M |
March 31, 2018 | -374.00M |
December 31, 2017 | 1.939B |
September 30, 2017 | -454.00M |
June 30, 2017 | 13.29B |
March 31, 2017 | -906.00M |
December 31, 2016 | -955.00M |
September 30, 2016 | -484.00M |
June 30, 2016 | -701.00M |
March 31, 2016 | -430.00M |
December 31, 2015 | -145.00M |
September 30, 2015 | -476.00M |
June 30, 2015 | -726.00M |
March 31, 2015 | 1.36B |
December 31, 2014 | 6.033B |
September 30, 2014 | -107.00M |
June 30, 2014 | -279.00M |
March 31, 2014 | -123.00M |
December 31, 2013 | -298.00M |
September 30, 2013 | -137.00M |
June 30, 2013 | -332.00M |
March 31, 2013 | -120.00M |
December 31, 2012 | -379.00M |
September 30, 2012 | -313.65M |
June 30, 2012 | -333.86M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.794B
Minimum
Jun 2023
1.705B
Maximum
Mar 2024
-187.30M
Average
-473.00M
Median
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 7.00M |
Abbott Laboratories | -1.576B |
Baxter International Inc | -146.00M |
Merit Medical Systems Inc | -47.57M |
ResMed Inc | -150.76M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 1.179B |
Cash from Investing (Quarterly) | -3.937B |
Free Cash Flow | 3.073B |
Free Cash Flow Per Share (Quarterly) | 3.038 |
Free Cash Flow to Equity (Quarterly) | 96.00M |
Free Cash Flow to Firm (Quarterly) | 959.90M |
Free Cash Flow Yield | 4.72% |